Cash flow IXICO plc

Stocks

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 11:35:19 2026-06-12 EDT			5-day change	1st Jan Change
8.650 ^GBX	0.00%		0.00%	-26.38%

06-08	Ixico plc Announces Appointments on Scientific Advisory Board	CI
06-08	Ixico Has Enters into A Research Collaboration with the Paris Brain Institute	CI

db5977fedf4ab65da626fc6.dlh9OFlHzllkfP1rXexteB8RsgtNiF5iaO9jD0eqUpI.AhQlfhh1oxwuFMk5a9suDmtXy08l6x8VIZoHQBjcFNQTEjd6NDSpGioWrA

Published financial data: IXICO PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	9.19M	8.64M	6.66M	5.77M	6.53M
Total Revenues	9.19M	8.64M	6.66M	5.77M	6.53M
Cost of Goods Sold, Total	3.17M	3.4M	3.4M	3.06M	3.35M
Gross Profit	6.02M	5.24M	3.27M	2.71M	3.18M
Selling General & Admin Expenses, Total	4.05M	3.81M	4.18M	4.31M	4.42M
R&D Expenses	1.24M	1.22M	925K	1.34M	1.33M
Other Operating Expenses	-448K	-689K	-393K	-781K	-15K
Other Operating Expenses, Total	4.84M	4.34M	4.71M	4.86M	5.74M
Operating Income	1.18M	908K	-1.44M	-2.15M	-2.55M
Interest Expense, Total	-22K	-33K	-29K	-25K	-16K
Interest And Investment Income	1K	10K	105K	85K	121K
Net Interest Expenses	-21K	-23K	76K	60K	105K
EBT, Excl. Unusual Items	1.16M	885K	-1.36M	-2.09M	-2.45M
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-	-
Asset Writedown	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	1.16M	885K	-1.36M	-2.09M	-2.45M
Income Tax Expense	-415K	-147K	-183K	-93K	-798K
Earnings From Continuing Operations	1.58M	1.03M	-1.18M	-2M	-1.65M
Net Income to Company	1.58M	1.03M	-1.18M	-2M	-1.65M
Net Income - (IS)	1.58M	1.03M	-1.18M	-2M	-1.65M
Net Income to Common Incl Extra Items	1.58M	1.03M	-1.18M	-2M	-1.65M
Net Income to Common Excl. Extra Items	1.58M	1.03M	-1.18M	-2M	-1.65M
Per Share Items
Net EPS - Basic	0.03	0.02	-0.02	-0.04	-0.02
Basic EPS - Continuing Operations	0.03	0.02	-0.02	-0.04	-0.02
Basic Weighted Average Shares Outstanding	47.66M	48.15M	48.31M	48.31M	89.47M
Net EPS - Diluted	0.03	0.02	-0.02	-0.04	-0.02
Diluted EPS - Continuing Operations	0.03	0.02	-0.02	-0.04	-0.02
Diluted Weighted Average Shares Outstanding	50.41M	50.76M	48.31M	48.31M	89.47M
Normalized Basic EPS	0.02	0.01	-0.02	-0.03	-0.02
Normalized Diluted EPS	0.01	0.01	-0.02	-0.03	-0.02
Supplemental Items
EBITDA	1.55M	1.29M	-1.09M	-1.94M	-2.4M
EBITA	1.22M	945K	-1.39M	-2.08M	-2.5M
EBIT	1.18M	908K	-1.44M	-2.15M	-2.55M
EBITDAR	1.55M	1.3M	-1.09M	-1.94M	-2.4M
Effective Tax Rate - (Ratio)	-35.78	-16.61	13.45	4.44	32.58
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	725K	553K	-851K	-1.31M	-1.53M
Interest on Long-Term Debt	22K	33K	29K	22K	19K
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.15M	1.23M	1.32M	1.4M	1.66M
General and Administrative Expenses	2.9M	2.58M	2.85M	2.91M	2.76M
Research And Development Expense From Footnotes	1.34M	1.37M	1.1M	1.5M	1.41M
Net Rental Expense, Total	2K	1K	1K	1K	1K
Imputed Operating Lease Interest Expense	869	474	514	571	519
Imputed Operating Lease Depreciation	1.13K	526	486	429	481
Stock-Based Comp., Other (Total)	204K	79K	52K	8K	227K
Total Stock-Based Compensation	204K	79K	52K	8K	227K

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	6.68M	5.77M	4.03M	1.79M	3.54M
Total Cash And Short Term Investments	6.68M	5.77M	4.03M	1.79M	3.54M
Accounts Receivable, Total	2.61M	2.25M	945K	1.63M	1.46M
Other Receivables	509K	487K	599K	529K	861K
Total Receivables	3.12M	2.73M	1.54M	2.16M	2.32M
Prepaid Expenses	552K	652K	684K	518K	366K
Other Current Assets, Total	-	96K	27K	24K	14K
Total Current Assets	10.36M	9.25M	6.29M	4.49M	6.23M
Gross Property Plant And Equipment	1.92M	2.08M	2.16M	2.23M	2.29M
Accumulated Depreciation	-841K	-1.27M	-1.65M	-1.88M	-2.06M
Net Property Plant And Equipment	1.08M	817K	518K	350K	222K
Other Intangibles, Total	2.71M	4.59M	6.15M	6.34M	7.13M
Accounts Receivable Long-Term	-	-	-	-	255K
Other Long-Term Assets, Total	-	-	39K	9K	-
Total Assets	14.15M	14.66M	12.99M	11.19M	13.84M
Liabilities
Accounts Payable, Total	734K	254K	86K	83K	75K
Accrued Expenses, Total	953K	508K	464K	553K	550K
Current Portion of Leases	78K	122K	112K	164K	149K
Current Income Taxes Payable	42K	56K	58K	180K	92K
Unearned Revenue Current, Total	475K	673K	529K	591K	1.19M
Other Current Liabilities	13K	122K	32K	3K	-
Total Current Liabilities	2.3M	1.74M	1.28M	1.57M	2.06M
Long-Term Leases	519K	394K	275K	150K	30K
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	114K	33K	2K	-	15K
Total Liabilities	2.93M	2.16M	1.56M	1.72M	2.1M
Common Stock, Total	482K	482K	484K	484K	927K
Additional Paid In Capital	84.8M	84.8M	84.8M	84.8M	88.06M
Retained Earnings	-7.6M	-6.23M	-7.36M	-9.35M	-10.78M
Comprehensive Income and Other	-66.46M	-66.56M	-66.49M	-66.47M	-66.47M
Total Common Equity	11.22M	12.49M	11.43M	9.46M	11.74M
Total Equity	11.22M	12.49M	11.43M	9.46M	11.74M
Total Liabilities And Equity	14.15M	14.66M	12.99M	11.19M	13.84M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	48.15M	48.15M	48.35M	48.35M	92.67M
ECS Total Common Shares Outstanding	48.15M	48.15M	48.35M	48.35M	92.67M
Book Value / Share	0.23	0.26	0.24	0.2	0.13
Tangible Book Value	8.51M	7.91M	5.28M	3.13M	4.61M
Tangible Book Value Per Share	0.18	0.16	0.11	0.06	0.05
Total Debt	597K	516K	387K	314K	179K
Net Debt	-6.09M	-5.25M	-3.64M	-1.47M	-3.36M
Debt Equivalent Oper. Leases	16K	8K	8K	8K	8K
Account Code - Inventory Valuation	3	-	3	3	3
Machinery, Total	960K	1.12M	1.2M	1.22M	1.22M
Full Time Employees	93	90	89	81	79
Order Backlog	18.8M	16M	14.8M	15.3M	13.8M

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	1.58M	1.03M	-1.18M	-2M	-1.65M
Depreciation & Amortization - CF	464K	451K	400K	241K	220K
Amortization of Goodwill and Intangible Assets - (CF)	40K	37K	47K	71K	57K
Depreciation & Amortization, Total	504K	488K	447K	312K	277K
Amortization of Deferred Charges, Total - (CF)	105K	151K	178K	163K	134K
(Gain) Loss From Sale Of Asset	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	41K	14K	-	-
Stock-Based Compensation (CF)	204K	79K	52K	8K	227K
Other Operating Activities, Total	-253K	49K	-174K	-6K	-413K
Change In Accounts Receivable	-1.11M	280K	1.29M	-559K	258K
Change In Accounts Payable	-410K	-696K	-327K	351K	161K
Cash from Operations	613K	1.42M	302K	-1.73M	-1.01M
Capital Expenditure	-170K	-187K	-100K	-34K	-51K
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-1.98M	-2.06M	-1.86M	-437K	-819K
Other Investing Activities, Total	1K	6K	99K	94K	124K
Cash from Investing	-2.15M	-2.24M	-1.86M	-377K	-746K
Long-Term Debt Repaid, Total	-44K	-114K	-158K	-134K	-194K
Total Debt Repaid	-44K	-114K	-158K	-134K	-194K
Issuance of Common Stock	314K	-	2K	-	3.7M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	270K	-114K	-156K	-134K	3.5M
Foreign Exchange Rate Adjustments	9K	14K	-20K	-1K	-
Net Change in Cash	-1.26M	-915K	-1.74M	-2.24M	1.75M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	-354K	-489K	-440K	-552K	-490K
Levered Free Cash Flow	-2.24M	-1.13M	-1.42M	-1.56M	-1.33M
Unlevered Free Cash Flow	-2.23M	-1.11M	-1.4M	-1.54M	-1.32M
Change In Net Working Capital	1.62M	154K	-783K	209K	-506K
Net Debt Issued / Repaid	-44K	-114K	-158K	-134K	-194K

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.62	3.93	-6.5	-11.14	-12.76
Return on Total Capital	6.98	4.52	-7.23	-12.47	-14.72
Return On Equity %	15.49	8.61	-9.85	-19.15	-15.57
Return on Common Equity	15.49	8.61	-9.85	-19.15	-15.57
Margin Analysis
Gross Profit Margin %	65.55	60.66	49.06	47.02	48.71
SG&A Margin	44.08	44.05	62.64	74.73	67.71
EBITDA Margin %	16.82	14.97	-16.38	-33.73	-36.76
EBITA Margin %	13.29	10.93	-20.86	-36.13	-38.22
EBIT Margin %	12.85	10.51	-21.56	-37.36	-39.09
Income From Continuing Operations Margin %	17.14	11.94	-17.67	-34.7	-25.27
Net Income Margin %	17.14	11.94	-17.67	-34.7	-25.27
Net Avail. For Common Margin %	17.14	11.94	-17.67	-34.7	-25.27
Normalized Net Income Margin	7.89	6.4	-12.76	-22.7	-23.43
Levered Free Cash Flow Margin	-24.37	-13.12	-21.29	-27.04	-20.39
Unlevered Free Cash Flow Margin	-24.22	-12.88	-21.02	-26.76	-20.24
Asset Turnover
Asset Turnover	0.7	0.6	0.48	0.48	0.52
Fixed Assets Turnover	8.77	9.11	9.99	13.29	22.85
Receivables Turnover (Average Receivables)	4.59	3.56	4.18	4.47	4.23
Short Term Liquidity
Current Ratio	4.51	5.33	4.91	2.85	3.03
Quick Ratio	4.27	4.9	4.35	2.51	2.85
Operating Cash Flow to Current Liabilities	0.27	0.82	0.24	-1.1	-0.49
Days Sales Outstanding (Average Receivables)	79.59	102.62	87.4	81.85	86.31
Average Days Payable Outstanding	52.46	53.03	18.28	10.12	8.6
Long Term Solvency
Total Debt/Equity	5.32	4.13	3.39	3.32	1.52
Total Debt / Total Capital	5.05	3.97	3.27	3.21	1.5
LT Debt/Equity	4.63	3.15	2.41	1.58	0.26
Long-Term Debt / Total Capital	4.39	3.03	2.33	1.53	0.25
Total Liabilities / Total Assets	20.69	14.75	11.99	15.41	15.19
EBIT / Interest Expense	53.68	27.52	-49.55	-86.16	-159.62
EBITDA / Interest Expense	76.59	42.3	-34.14	-73.68	-142.31
(EBITDA - Capex) / Interest Expense	68.86	36.64	-37.59	-75.04	-145.5
Total Debt / EBITDA	0.35	0.37	-0.39	-0.17	-0.08
Net Debt / EBITDA	-3.61	-3.76	3.68	0.8	1.47
Total Debt / (EBITDA - Capex)	0.39	0.43	-0.36	-0.17	-0.08
Net Debt / (EBITDA - Capex)	-4.02	-4.34	3.34	0.79	1.44
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.59	-5.95	-22.89	-13.49	13.32
Gross Profit, 1 Yr. Growth %	-5.07	-12.96	-37.63	-17.09	17.41
EBITDA, 1 Yr. Growth %	46.96	-12.74	-184.39	78.11	22.3
EBITA, 1 Yr. Growth %	37.66	-18.39	-247.09	49.86	18.79
EBIT, 1 Yr. Growth %	37.97	-18.78	-258.26	49.9	18.57
Earnings From Cont. Operations, 1 Yr. Growth %	65.44	-31.75	-214.15	69.86	-17.49
Net Income, 1 Yr. Growth %	65.44	-31.75	-214.15	69.86	-17.49
Normalized Net Income, 1 Yr. Growth %	35.2	-19.33	-253.79	53.86	16.95
Diluted EPS Before Extra, 1 Yr. Growth %	56.01	-32.33	-220.19	69.76	-55.34
Accounts Receivable, 1 Yr. Growth %	87.31	-14.01	-57.94	72.91	-10.89
Net Property, Plant and Equip., 1 Yr. Growth %	6.61	-24.42	-36.6	-32.43	-36.57
Total Assets, 1 Yr. Growth %	16.97	2.77	-11.36	-13.87	23.7
Tangible Book Value, 1 Yr. Growth %	2.26	-9.84	-33.15	-40.83	47.39
Common Equity, 1 Yr. Growth %	23.05	8.83	-8.49	-17.21	24.02
Cash From Operations, 1 Yr. Growth %	-68.02	132.3	-78.79	-673.51	-41.86
Capital Expenditures, 1 Yr. Growth %	-75.22	10	-46.52	-66	50
Levered Free Cash Flow, 1 Yr. Growth %	-1.13K	-55.3	25.14	9.84	-14.54
Unlevered Free Cash Flow, 1 Yr. Growth %	-1.08K	-55.87	25.83	10.14	-14.32
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	10.25	-4.78	-14.84	-18.32	-0.99
Gross Profit, 2 Yr. CAGR %	10.41	-9.11	-26.32	-28.09	-1.34
EBITDA, 2 Yr. CAGR %	83.53	10.91	-14.19	22.6	48.31
EBITA, 2 Yr. CAGR %	77.62	3.22	9.56	48.47	34.03
EBIT, 2 Yr. CAGR %	80.13	2.99	13.37	54.02	33.32
Earnings From Cont. Operations, 2 Yr. CAGR %	90.94	4.12	-11.73	39.25	18.39
Net Income, 2 Yr. CAGR %	90.94	4.12	-11.73	39.25	18.39
Normalized Net Income, 2 Yr. CAGR %	78.03	1.56	11.38	53.82	34.14
Diluted EPS Before Extra, 2 Yr. CAGR %	84.16	0.75	-9.82	42.84	-12.92
Accounts Receivable, 2 Yr. CAGR %	16.27	26.92	-39.86	-14.72	24.13
Net Property, Plant and Equip., 2 Yr. CAGR %	84.96	-10.24	-30.78	-34.55	-34.53
Total Assets, 2 Yr. CAGR %	14.99	10.07	-4.56	-12.63	3.22
Tangible Book Value, 2 Yr. CAGR %	5.64	-2.54	-22.37	-37.11	-6.61
Common Equity, 2 Yr. CAGR %	19.04	17.05	-0.2	-12.96	1.33
Cash From Operations, 2 Yr. CAGR %	117.15	-13.81	-29.81	10.29	82.6
Capital Expenditures, 2 Yr. CAGR %	-11.49	-47.79	-23.3	-57.36	-28.59
Levered Free Cash Flow, 2 Yr. CAGR %	72.18	128.74	-25.21	17.24	-3.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	71.65	120.99	-25.48	17.73	-2.86
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	19.44	4.56	-11.24	-14.39	-8.9
Gross Profit, 3 Yr. CAGR %	23.82	1.99	-19.83	-23.37	-15.33
EBITDA, 3 Yr. CAGR %	32.87	41.27	1.25	9.46	22.9
EBITA, 3 Yr. CAGR %	20.55	34.66	16.15	21.62	38.25
EBIT, 3 Yr. CAGR %	14.01	35.62	18.85	24.43	41.16
Earnings From Cont. Operations, 3 Yr. CAGR %	33.1	33.68	7.36	9.79	16.96
Net Income, 3 Yr. CAGR %	33.1	33.68	7.36	9.79	16.96
Normalized Net Income, 3 Yr. CAGR %	13.52	34.22	16.62	24.05	40.39
Diluted EPS Before Extra, 3 Yr. CAGR %	15.98	30.19	6.85	11.35	-3.05
Accounts Receivable, 3 Yr. CAGR %	11.92	5.15	-12.17	-14.49	-13.47
Net Property, Plant and Equip., 3 Yr. CAGR %	141.24	37.25	-20.06	-31.33	-35.23
Total Assets, 3 Yr. CAGR %	11.02	11.05	2.41	-7.77	-1.89
Tangible Book Value, 3 Yr. CAGR %	5.28	1.2	-14.05	-29.09	-16.46
Common Equity, 3 Yr. CAGR %	15.27	16.41	7.83	-6.23	-2.06
Cash From Operations, 3 Yr. CAGR %	19.97	122.09	-45.99	41.37	-10.91
Capital Expenditures, 3 Yr. CAGR %	41.5	-4.84	-47.37	-41.52	-35.15
Levered Free Cash Flow, 3 Yr. CAGR %	68.17	14.5	87.08	-14.98	5.51
Unlevered Free Cash Flow, 3 Yr. CAGR %	67.83	13.8	83.17	-15.12	5.89
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	22.97	16.08	4.32	-5.28	-7.27
Gross Profit, 5 Yr. CAGR %	30.56	17.77	0.6	-11.32	-12.89
EBITDA, 5 Yr. CAGR %	-3.18	0.87	10.63	33.48	17.95
EBITA, 5 Yr. CAGR %	-8.19	-6.01	14.8	40.02	23
EBIT, 5 Yr. CAGR %	-11.41	-8.7	12.51	42.7	24.44
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.76	-7.66	12.01	35.88	11.64
Net Income, 5 Yr. CAGR %	-5.76	-7.66	12.01	35.88	11.64
Normalized Net Income, 5 Yr. CAGR %	-11.72	-9.16	11.41	41.74	23.34
Diluted EPS Before Extra, 5 Yr. CAGR %	-18.55	-18.68	4.06	35.11	-1.55
Accounts Receivable, 5 Yr. CAGR %	20.84	12.5	-12.7	-3.3	0.86
Net Property, Plant and Equip., 5 Yr. CAGR %	65.15	68.58	46.41	2.06	-26.2
Total Assets, 5 Yr. CAGR %	20.02	26.58	4.67	0.89	2.73
Tangible Book Value, 5 Yr. CAGR %	19.27	25.29	-6.24	-16.33	-11.15
Common Equity, 5 Yr. CAGR %	22.4	35.96	9.31	3.63	5.18
Cash From Operations, 5 Yr. CAGR %	-16.77	17.2	-3.18	67.85	-12.08
Capital Expenditures, 5 Yr. CAGR %	47.93	54.85	10.76	-30.98	-40.54
Levered Free Cash Flow, 5 Yr. CAGR %	19.62	37.43	24.69	15.59	43.79
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.47	36.92	24.37	15.36	42.13